Literature DB >> 28625410

Sialadenoma papilliferum in the buccal mucosa detected on 18F-fluorodeoxyglucose-positron emission tomography.

S Miyamoto1, T Ogawa2, D Chikazu3.   

Abstract

An incidental discovery of an accumulation of 18F-fluorodeoxyglucose (FDG) in the oral cavity of patients with malignant tumours on FDG positron emission tomography (PET) can pose a problem regarding the differential diagnosis of metastatic lesions. Large accumulations can often be found even when tumours in the salivary or thyroid gland are benign, so FDG-PET is limited in its ability to differentiate between benign and malignant disease. This report describes a rare case of sialadenoma papilliferum in the buccal mucosa that was discovered incidentally on FDG-PET in a patient with multiple metastases to bone after an operation for rectal cancer.
Copyright © 2017 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  FDG-PET; differential diagnosis; malignant tumours; sialadenoma papilliferum

Mesh:

Substances:

Year:  2017        PMID: 28625410     DOI: 10.1016/j.bjoms.2017.05.004

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  3 in total

Review 1.  Sialadenoma papilliferum: Bibliometric analysis.

Authors:  Antonio-Jorge-Araújo de Vasconcelos Ii; Luana-Rafaela Gerber; Stanny-Hagath-Maciel Saraiva; Pâmela-Oliveira de Vasconcelos; Lioney-Nobre Cabral; Tiago-Novaes Pinheiro
Journal:  J Clin Exp Dent       Date:  2019-09-01

2.  Sialadenoma papilliferum: clinicopathologic, Immunohistochemical, molecular analyses of new five cases and review of the literature.

Authors:  Shuai Chen; Jie Peng; Chuantao Yuan; Lin Sun; Renya Zhang; Yan Sun
Journal:  Diagn Pathol       Date:  2021-03-12       Impact factor: 2.644

3.  Case Report: Papillary Lesions at the Mouth Floor May Mimic Sialadenoma Papilliferum.

Authors:  Dawool Han; Eunae Sandra Cho; Jiho Park; Dongwook Kim
Journal:  Pathol Oncol Res       Date:  2022-07-14       Impact factor: 2.874

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.